The differential prognostic implications of PD-L1 expression in the outcomes of Filipinos with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors

por Luna, Herdee Gloriane C., Imasa, Marcelo Severino, Juat, Necy, Hernandez, Katherine V., Sayo, Treah May, Cristal-Luna, Gloria, Asur-Galang, Sheena Marie, Bellengan, Mirasol, Duga, Kent John, Buenaobra, Bien Brian, De los Santos, Marvin I., Medina, Daniel, Samo, Jamirah, Literal, Venus Minerva, Bascos, Neil Andrew, Sy-Naval, Sullian
Publicado 2023